Psychiatric Times
Vol 41, Issue 1
Vol 40, Issue 12
Vol 40, Issue 11
Vol 40, Issue 10
Vol 40, Issue 9
Vol 40, Issue 8
Vol 40, Issue 7
Vol 40, Issue 6
Vol 40, Issue 5
Vol 40, Issue 4
Vol 40, Issue 3
Vol 40, Issue 2
Vol 40, Issue 1
Vol 39, Issue 12
Vol 39, Issue 11
Vol 39, Issue 10
Vol 39, Issue 9
Volume 39, Issue 9 Psychedelics Supplement
Vol 39, Issue 8
Vol 39, Issue 7
Vol 39, Issue 6
Vol 39, Issue 5
Vol 39, Issue 4
Vol 39, Issue 3
Vol 39, Issue 2
Vol 39, Issue 1
Vol 38, Issue 12 Sleep Supplement
Vol 38, Issue 12
Vol 38, Issue 11
Vol 38, Issue 10
Advertisement
Advertisement
Trending on Psychiatric Times
1
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
2
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
3
Monoamines: A Full House
4
What Do Orexin-2 Receptor Agonists Mean for Psychiatry?
5